{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:21:51Z","timestamp":1792858911331,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fraunhofer-Institut f\u00fcr Algorithmen und Wissenschaftliches Rechnen SCAI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Digital technologies for monitoring motor symptoms of Parkinson\u2019s Disease (PD) underwent a strong evolution during the past years. Although it has been shown for several devices that derived digital gait features can reliably discriminate between healthy controls and people with PD, the specific gait tasks best suited for monitoring motor symptoms and especially their progression, remain unclear. Furthermore, the potential benefit as endpoint in a clinical trial context has not been investigated so far. In this study we employed a digital gait device manufactured by Portabiles HCT, which has been used by 339 patients within the LuxPark cohort (n\u2009=\u2009161, Luxembourg) as well as within routine clinical care visits at the University Medical Center Erlangen (n\u2009=\u2009178, Erlangen, Germany). Linear (mixed) models were used to assess the association of task-specific digital gait features with disease progression and motor symptom severity measured by several clinical scores. Furthermore, we employed machine learning to evaluate whether digital gait assessments were prognostic for patient-level motor symptom progression. Overall, digital gait features derived from Portabiles digital gait device were found to effectively monitor motor symptoms and their longitudinal progression. At the same time the prognostic performance of digital gait features was limited. However, we could show a strong reduction in required sample size, if digital gait features were employed as surrogates for traditional endpoints in a clinical trial context. Thus, Portabiles digital gait device provides an effective way to objectively monitor motor symptoms and their progression in PD. Furthermore, the digital gait device bears strong potential as an alternative and easily assessable endpoint predictor in a clinical trial context.<\/jats:p>","DOI":"10.1038\/s41598-025-09088-7","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:12:53Z","timestamp":1752577973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Objective monitoring of motor symptom severity and their progression in Parkinson\u2019s disease using a digital gait device"],"prefix":"10.1038","volume":"15","author":[{"given":"Tamara","family":"Raschka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackrite","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"H\u00e4hnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzhraa","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Glaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Ga\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Klucken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"9088_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease: MDS-PD clinical diagnostic criteria. Mov. Disord. 30, 1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424 (2015).","journal-title":"Mov. Disord."},{"key":"9088_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa, A. A. et al. Motor symptoms in Parkinson\u2019s disease: A unified framework. Neurosci. Biobehav. Rev. 68, 727\u2013740. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.07.010 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"9088_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12264-012-1050-z","volume":"28","author":"R Xia","year":"2012","unstructured":"Xia, R. & Mao, Z.-H. Progression of motor symptoms in Parkinson\u2019s disease. Neurosci. Bull. 28, 39\u201348. https:\/\/doi.org\/10.1007\/s12264-012-1050-z (2012).","journal-title":"Neurosci. Bull."},{"key":"9088_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","volume":"18","author":"A Mirelman","year":"2019","unstructured":"Mirelman, A. et al. Gait impairments in Parkinson\u2019s disease. Lancet Neurol. 18, 697\u2013708. https:\/\/doi.org\/10.1016\/S1474-4422(19)30044-4 (2019).","journal-title":"Lancet Neurol."},{"key":"9088_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41746-022-00568-y","volume":"5","author":"AS Chandrabhatla","year":"2022","unstructured":"Chandrabhatla, A. S., Pomeraniec, I. J. & Ksendzovsky, A. Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson\u2019s disease motor symptoms. Npj Digit Med. 5, 32. https:\/\/doi.org\/10.1038\/s41746-022-00568-y (2022).","journal-title":"Npj Digit Med."},{"key":"9088_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.788427","volume":"13","author":"H Fr\u00f6hlich","year":"2022","unstructured":"Fr\u00f6hlich, H. et al. Leveraging the potential of digital technology for better individualized treatment of Parkinson\u2019s disease. Front. Neurol. 13, 788427. https:\/\/doi.org\/10.3389\/fneur.2022.788427 (2022).","journal-title":"Front. Neurol."},{"key":"9088_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement disorder society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340 (2008).","journal-title":"Mov. Disord."},{"key":"9088_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3233\/JPD-230044","volume":"13","author":"C Kirk","year":"2023","unstructured":"Kirk, C. et al. Can digital mobility assessment enhance the clinical assessment of disease severity in Parkinson\u2019s disease?. J. Park. Dis. 13, 999\u20131009. https:\/\/doi.org\/10.3233\/JPD-230044 (2023).","journal-title":"J. Park. Dis."},{"key":"9088_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/09544119231197090","author":"P Nair","year":"2023","unstructured":"Nair, P., Shojaei Baghini, M., Pendharkar, G. & Chung, H. Detecting early-stage Parkinson\u2019s disease from gait data. Proc. Inst. Mech. Eng. https:\/\/doi.org\/10.1177\/09544119231197090 (2023).","journal-title":"Proc. Inst. Mech. Eng."},{"key":"9088_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s42003-022-03002-x","volume":"5","author":"K Deng","year":"2022","unstructured":"Deng, K. et al. Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson\u2019s disease. Commun. Biol. 5, 58. https:\/\/doi.org\/10.1038\/s42003-022-03002-x (2022).","journal-title":"Commun. Biol."},{"key":"9088_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/01616412.2017.1348690","volume":"39","author":"M Djuri\u0107-Jovi\u010di\u0107","year":"2017","unstructured":"Djuri\u0107-Jovi\u010di\u0107, M., Beli\u0107, M., Stankovi\u0107, I., Radovanovi\u0107, S. & Kosti\u0107, V. S. Selection of gait parameters for differential diagnostics of patients with de novo Parkinson\u2019s disease. Neurol. Res. 39, 853\u2013861. https:\/\/doi.org\/10.1080\/01616412.2017.1348690 (2017).","journal-title":"Neurol. Res."},{"key":"9088_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41531-023-00497-x","volume":"9","author":"JL Adams","year":"2023","unstructured":"Adams, J. L. et al. Using a smartwatch and smartphone to assess early Parkinson\u2019s disease in the WATCH-PD study. Npj Park. Dis. 9, 64. https:\/\/doi.org\/10.1038\/s41531-023-00497-x (2023).","journal-title":"Npj Park. Dis."},{"key":"9088_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.11138\/FNeur\/2017.32.1.028","volume":"32","author":"M Pistacchi","year":"2017","unstructured":"Pistacchi, M. Gait analysis and clinical correlations in early Parkinson\u2019s disease. Funct. Neurol. 32, 28. https:\/\/doi.org\/10.11138\/FNeur\/2017.32.1.028 (2017).","journal-title":"Funct. Neurol."},{"key":"9088_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/gerona\/glad101","volume":"78","author":"G Cai","year":"2023","unstructured":"Cai, G. et al. Specific distribution of digital gait biomarkers in Parkinson\u2019s disease using body-worn sensors and machine learning. J. Gerontol. Ser. A 78, 1348\u20131354. https:\/\/doi.org\/10.1093\/gerona\/glad101 (2023).","journal-title":"J. Gerontol. Ser. A"},{"key":"9088_CR15","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1007\/s00415-022-11312-7","volume":"269","author":"E Beswick","year":"2022","unstructured":"Beswick, E. et al. A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease. J. Neurol. 269, 6254\u20136268. https:\/\/doi.org\/10.1007\/s00415-022-11312-7 (2022).","journal-title":"J. Neurol."},{"key":"9088_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/brainsci12091213","volume":"12","author":"S Zhu","year":"2022","unstructured":"Zhu, S. et al. Gait analysis with wearables is a potential progression marker in Parkinson\u2019s disease. Brain Sci. 12, 1213. https:\/\/doi.org\/10.3390\/brainsci12091213 (2022).","journal-title":"Brain Sci."},{"key":"9088_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41746-022-00619-4","volume":"5","author":"JA Diao","year":"2022","unstructured":"Diao, J. A., Raza, M. M., Venkatesh, K. P. & Kvedar, J. C. Watching Parkinson\u2019s disease with wrist-based sensors. Npj Digit. Med. 5, 73. https:\/\/doi.org\/10.1038\/s41746-022-00619-4 (2022).","journal-title":"Npj Digit. Med."},{"key":"9088_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1177\/0962280217737566","volume":"28","author":"D Li","year":"2019","unstructured":"Li, D., Iddi, S., Thompson, W. K. & Donohue, M. C. Bayesian latent time joint mixed effect models for multicohort longitudinal data. Stat. Methods Med. Res. 28, 835\u2013845. https:\/\/doi.org\/10.1177\/0962280217737566 (2019).","journal-title":"Stat. Methods Med. Res."},{"key":"9088_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fnagi.2018.00326","volume":"10","author":"G Hipp","year":"2018","unstructured":"Hipp, G. et al. The Luxembourg Parkinson\u2019s Study: A comprehensive approach for stratification and early diagnosis. Front. Aging Neurosci. 10, 326. https:\/\/doi.org\/10.3389\/fnagi.2018.00326 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"9088_CR20","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","volume":"39","author":"D Aleksovski","year":"2018","unstructured":"Aleksovski, D., Miljkovic, D., Bravi, D. & Antonini, A. Disease progression in Parkinson subtypes: The PPMI dataset. Neurol. Sci. 39, 1971\u20131976. https:\/\/doi.org\/10.1007\/s10072-018-3522-z (2018).","journal-title":"Neurol. Sci."},{"key":"9088_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.888701","volume":"16","author":"Y Hayashi","year":"2022","unstructured":"Hayashi, Y. et al. Unilateral GPi-DBS improves ipsilateral and axial motor symptoms in Parkinson\u2019s disease as evidenced by a brain perfusion single photon emission computed tomography study. Front. Hum. Neurosci. 16, 888701. https:\/\/doi.org\/10.3389\/fnhum.2022.888701 (2022).","journal-title":"Front. Hum. Neurosci."},{"key":"9088_CR22","unstructured":"Fahn S. Unified Parkinson\u2019s disease rating scale. Recent Dev Park Dis. 1987; 153\u2013163."},{"key":"9088_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo, D. & Richardson, S. The timed \u201cUp & Go\u201d: A test of basic functional mobility for frail elderly persons. J. Am. Geriatr. Soc. 39, 142\u2013148. https:\/\/doi.org\/10.1111\/j.1532-5415.1991.tb01616.x (1991).","journal-title":"J. Am. Geriatr. Soc."},{"key":"9088_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41531-024-00712-3","volume":"10","author":"T H\u00e4hnel","year":"2024","unstructured":"H\u00e4hnel, T. et al. Progression subtypes in Parkinson\u2019s disease identified by a data-driven multi cohort analysis. Npj Park. Dis. 10, 95. https:\/\/doi.org\/10.1038\/s41531-024-00712-3 (2024).","journal-title":"Npj Park. Dis."},{"key":"9088_CR25","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1013699998","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y. & Yekutieli, D. The control of the false discovery rate in multiple testing under dependency. Ann. Stat. https:\/\/doi.org\/10.1214\/aos\/1013699998 (2001).","journal-title":"Ann. Stat."},{"key":"9088_CR26","unstructured":"UCB Biopharma SRL. A Double-Blind, Placebo-Controlled, Randomized, 18-Month Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral UCB0599 in Study Participants With Early Parkinson\u2019s Disease. clinicaltrials.gov. 2023. Available: https:\/\/clinicaltrials.gov\/study\/NCT04658186 (accessed July 16, 2023)"},{"key":"9088_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2011-0062","volume":"26","author":"MC Ard","year":"2011","unstructured":"Ard, M. C. & Edland, S. D. Power calculations for clinical trials in Alzheimer\u2019s disease. J. Alzheimers Dis. 26, 369\u2013377. https:\/\/doi.org\/10.3233\/JAD-2011-0062 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"9088_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.32614\/RJ-2022-022","volume":"14","author":"S Iddi","year":"2022","unstructured":"Iddi, S. & Donohue, M. Power and sample size for longitudinal models in R\u2014The longpower package and shiny. Appl. Res. J. 14, 264\u2013282. https:\/\/doi.org\/10.32614\/RJ-2022-022 (2022).","journal-title":"Appl. Res. J."},{"key":"9088_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324 (2001).","journal-title":"Mach. Learn."},{"key":"9088_CR30","doi-asserted-by":"publisher","unstructured":"Chen, T. & Guestrin, C. XGBoost: A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco California USA: ACM; 2016. pp. 785\u2013794. https:\/\/doi.org\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"key":"9088_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani, R. Regression shrinkage and selection via the Lasso. J. R. Stat. Soc. Ser. B Methodol. 58, 267\u2013288. https:\/\/doi.org\/10.1111\/j.2517-6161.1996.tb02080.x (1996).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"9088_CR32","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"9088_CR33","doi-asserted-by":"publisher","unstructured":"Lundberg, S. & Lee, S.-I. A Unified Approach to Interpreting Model Predictions. arXiv; 2017. https:\/\/doi.org\/10.48550\/arXiv.1705.07874","DOI":"10.48550\/arXiv.1705.07874"},{"key":"9088_CR34","doi-asserted-by":"publisher","first-page":"e0183989","DOI":"10.1371\/journal.pone.0183989","volume":"12","author":"JCM Schlachetzki","year":"2017","unstructured":"Schlachetzki, J. C. M. et al. Wearable sensors objectively measure gait parameters in Parkinson\u2019s disease. PLoS ONE 12, e0183989. https:\/\/doi.org\/10.1371\/journal.pone.0183989 (2017).","journal-title":"PLoS ONE"},{"key":"9088_CR35","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/s21072292","volume":"21","author":"J Welzel","year":"2021","unstructured":"Welzel, J. et al. Step Length is a promising progression marker in Parkinson\u2019s disease. Sensors. 21, 2292. https:\/\/doi.org\/10.3390\/s21072292 (2021).","journal-title":"Sensors."},{"key":"9088_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.parkreldis.2011.09.006","volume":"18","author":"AH Snijders","year":"2012","unstructured":"Snijders, A. H., Haaxma, C. A., Hagen, Y. J., Munneke, M. & Bloem, B. R. Freezer or non-freezer: Clinical assessment of freezing of gait. Parkinsonism Relat. Disord. 18, 149\u2013154. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.09.006 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"9088_CR37","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1002\/mds.23327","volume":"25","author":"J Spildooren","year":"2010","unstructured":"Spildooren, J. et al. Freezing of gait in Parkinson\u2019s disease: The impact of dual-tasking and turning. Mov. Disord. 25, 2563\u20132570. https:\/\/doi.org\/10.1002\/mds.23327 (2010).","journal-title":"Mov. Disord."},{"key":"9088_CR38","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s00415-019-09382-1","volume":"267","author":"C Raccagni","year":"2020","unstructured":"Raccagni, C. et al. Gait and postural disorders in Parkinsonism: A clinical approach. J. Neurol. 267, 3169\u20133176. https:\/\/doi.org\/10.1007\/s00415-019-09382-1 (2020).","journal-title":"J. Neurol."},{"key":"9088_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-022-11354-x","volume":"270","author":"S Cao","year":"2023","unstructured":"Cao, S. et al. Prevalence of axial postural abnormalities and their subtypes in Parkinson\u2019s disease: A systematic review and meta-analysis. J. Neurol. 270, 139\u2013151. https:\/\/doi.org\/10.1007\/s00415-022-11354-x (2023).","journal-title":"J. Neurol."},{"key":"9088_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.parkreldis.2022.10.026","volume":"105","author":"C Pongmala","year":"2022","unstructured":"Pongmala, C. et al. Gait and axial postural abnormalities correlations in Parkinson\u2019s disease: A multicenter quantitative study. Parkinsonism Relat. Disord. 105, 19\u201323. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.10.026 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"9088_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/mds.30056","volume":"40","author":"P R\u00e1bano-Su\u00e1rez","year":"2025","unstructured":"R\u00e1bano-Su\u00e1rez, P. et al. Digital outcomes as biomarkers of disease progression in early Parkinson\u2019s disease: A systematic review. Mov. Disord. 40, 184\u2013203. https:\/\/doi.org\/10.1002\/mds.30056 (2025).","journal-title":"Mov. Disord."},{"key":"9088_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-024-01236-z","volume":"7","author":"C Brzenczek","year":"2024","unstructured":"Brzenczek, C., Klopfenstein, Q., H\u00e4hnel, T., Fr\u00f6hlich, H. & Glaab, E. Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson\u2019s disease. Npj Digit. Med. 7, 1\u201316. https:\/\/doi.org\/10.1038\/s41746-024-01236-z (2024).","journal-title":"Npj Digit. Med."},{"key":"9088_CR43","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.3390\/s20123529","volume":"20","author":"L Di Biase","year":"2020","unstructured":"Di Biase, L. et al. Gait analysis in Parkinson\u2019s disease: An overview of the most accurate markers for diagnosis and symptoms monitoring. Sensors. 20, 3529. https:\/\/doi.org\/10.3390\/s20123529 (2020).","journal-title":"Sensors."},{"key":"9088_CR44","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.3390\/s20092631","volume":"20","author":"L Coates","year":"2020","unstructured":"Coates, L., Shi, J., Rochester, L., Del Din, S. & Pantall, A. Entropy of real-world gait in Parkinson\u2019s disease determined from wearable sensors as a digital marker of altered ambulatory behavior. Sensors 20, 2631. https:\/\/doi.org\/10.3390\/s20092631 (2020).","journal-title":"Sensors"},{"key":"9088_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnhum.2019.00059","volume":"13","author":"ME Mic\u00f3-Amigo","year":"2019","unstructured":"Mic\u00f3-Amigo, M. E. et al. Potential markers of progression in idiopathic Parkinson\u2019s disease derived from assessment of circular gait with a single body-fixed-sensor: A 5 year longitudinal study. Front. Hum. Neurosci. 13, 59. https:\/\/doi.org\/10.3389\/fnhum.2019.00059 (2019).","journal-title":"Front. Hum. Neurosci."},{"key":"9088_CR46","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz, C. G. et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations the movement disorder society task force on rating scales for Parkinson\u2019s disease. Mov. Disord. 19, 1020\u20131028. https:\/\/doi.org\/10.1002\/mds.20213 (2004).","journal-title":"Mov. Disord."},{"key":"9088_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-021-00227-1","volume":"7","author":"G Di Lazzaro","year":"2021","unstructured":"Di Lazzaro, G. et al. Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson\u2019s disease cohort. NPJ Park Dis. 7, 82. https:\/\/doi.org\/10.1038\/s41531-021-00227-1 (2021).","journal-title":"NPJ Park Dis."},{"key":"9088_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnagi.2019.00022","volume":"11","author":"MA Hobert","year":"2019","unstructured":"Hobert, M. A. et al. Progressive gait deficits in Parkinson\u2019s disease: A wearable-based biannual 5-year prospective study. Front. Aging Neurosci. 11, 22. https:\/\/doi.org\/10.3389\/fnagi.2019.00022 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"9088_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adc9669","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Monitoring gait at home with radio waves in Parkinson\u2019s disease: A marker of severity, progression, and medication response. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.adc9669 (2022).","journal-title":"Sci. Transl. Med."},{"key":"9088_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd7865","author":"R Powers","year":"2021","unstructured":"Powers, R. et al. Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson\u2019s disease. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abd7865 (2021).","journal-title":"Sci. Transl. Med."},{"key":"9088_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-020-00334-y","volume":"3","author":"MD Czech","year":"2020","unstructured":"Czech, M. D. et al. Age and environment-related differences in gait in healthy adults using wearables. Npj Digit. Med. 3, 1\u20139. https:\/\/doi.org\/10.1038\/s41746-020-00334-y (2020).","journal-title":"Npj Digit. Med."},{"key":"9088_CR52","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/mds.29450","volume":"38","author":"T Payne","year":"2023","unstructured":"Payne, T. et al. A double-blind, randomized, placebo-controlled trial of ursodeoxycholic acid ( UDCA) in Parkinson\u2019s disease. Mov. Disord. 38, 1493\u20131502. https:\/\/doi.org\/10.1002\/mds.29450 (2023).","journal-title":"Mov. Disord."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09088-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09088-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09088-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:12:55Z","timestamp":1752577975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09088-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9088"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09088-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4521747\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ralph Steidl is the CEO of Portabiles HCT. Jochen Klucken holds shares of Portabiles HCT. Jean-Christophe Corvol has served in advisory boards for Alzprotect, Bayer, Biogen, Denali, Ferrer, Idorsia, iRegene, Prevail Therapeutic, Servier, Theranexus, UCB; and received grants from Sanofi and the Michael J Fox Foundation outside of this work. Holger Fr\u00f6hlich has received grants from UCB and AbbVie outside this work. Tamara Raschka,  Jackrite To, Tom H\u00e4hnel, Stefano Sapienza, Alzhraa Ibrahim, Enrico Glaab, Heiko Ga\u00dfner, and J\u00fcrgen Winkler declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25541"}}